BioSpace News Archive

The global Genomic Biomarkers market accounted for USD 5.5 billion in 2020 and is expected to reach USD 19.7 billion by 2028, growing at a CAGR of around 17.5% between 2021 and 2028.

IDEAYA Biosciences, Inc. announced that it intends to offer and sell up to $80 million of shares of its common stock in an underwritten public offering.

Hillrom will host its fiscal third quarter 2021 earnings conference call and webcast on Friday, July 30, 2021, beginning at 7:30 a.m. / 8:30 a.m..

Rise in global geriatric population and increasing adoption of technologically advanced arthroscopy tools and devices are the key factors contributing to market growth.

The report highlights the trends prevailing in the market, along with market drivers and deterrents. Increasing elderly population in world and rising demand for minimally invasive procedures are among the key forces driving the market growth.

The report highlights trends prevailing in the market and the factors driving and restraining the market growth.

ValnevaSE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, announced it has appointed Vincent Dequenne as Senior Vice President Operations and Joshua Drumm as Vice President Investor Relations.

Subject to the accelerator provisions, the exercise period of Warrants will be reduced to thirty (30) days, if, for any ten consecutive trading days during the unexpired term of the Warrants, the weighted average closing price of the Company’s listed shares achieves or exceeds the price of 120% of the applicable exercise price ($0.66).

The cancer tissue diagnostics market is US$ 2,025.41 Mn in 2018 and is predicted to grow at a CAGR of 6.2% during the forecast period 2019 – 2027, to reach US$ 3,419.61 Mn by 2027.

The subcutaneous drug delivery devices market is expected to reach US$ 17,290.47 Mn in 2027 from US$ 9,243.80 in 2018.